Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Determine which is better for saving: Cash App or a traditional savings account. This guide provides insights to help you decide.
25,577 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
EVgo’s growth hinges on expanding its fast-charging network and capitalizing on policy support. This article outlines...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
When a top investor adds to a position after a selloff, it can reveal confidence not just in a single company, but in...
Intuitive Machines announced an $800 million acquisition that pivots the company from lunar landers to a full space p...
A new ETF focused on global dividend growers aims to deliver steady income and long-term growth. Retirees weigh modes...
As traditional bonds yield less in a volatile rate environment, retirees are turning to covered-call ETFs such as JEP...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...